Table 1.
Baseline characteristics of people living with HIV experiencing virologic failure in Chongqing, China, 2019–2023.
Table 2.
Prevalence of drug resistance mutations across HIV-1 subtypes among patients with virologic failure in Chongqing, 2019–2023.
Table 3.
Spectrum of major drug resistance mutations by antiretroviral drug class among patients with virologic failure in Chongqing, 2019–2023.
Table 4.
Univariate analysis of factors associated with drug resistance mutations among patients with virologic failure in Chongqing, 2019–2023.
Table 5.
Multivariate logistic regression analysis of factors independently associated with drug resistance mutations among patients with virologic failure.